Singapore markets closed

Aeterna Zentaris Inc. (AEZS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.59-0.12 (-2.10%)
As of 10:06AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 17.90M
Enterprise value 16.00M
Trailing P/E 9.27
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.66
Price/book (mrq)0.94
Enterprise value/revenue 2.46
Enterprise value/EBITDA 3.33

Trading information

Stock price history

Beta (5Y monthly) 2.16
52-week change 31,662.58%
S&P500 52-week change 320.87%
52-week high 39.32
52-week low 30.15
50-day moving average 36.60
200-day moving average 34.82

Share statistics

Avg vol (3-month) 34.88k
Avg vol (10-day) 316.34k
Shares outstanding 53.06M
Implied shares outstanding 63.06M
Float 81.12M
% held by insiders 11.59%
% held by institutions 16.26%
Shares short (28 Jun 2024) 49.3k
Short ratio (28 Jun 2024) 41.37
Short % of float (28 Jun 2024) 4N/A
Short % of shares outstanding (28 Jun 2024) 40.19%
Shares short (prior month 31 May 2024) 4409

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 303 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-152,750.00%

Management effectiveness

Return on assets (ttm)-29.96%
Return on equity (ttm)-81.71%

Income statement

Revenue (ttm)2.37M
Revenue per share (ttm)1.96
Quarterly revenue growth (yoy)-99.80%
Gross profit (ttm)N/A
EBITDA -19.89M
Net income avi to common (ttm)-18.05M
Diluted EPS (ttm)-2.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)29.55M
Total cash per share (mrq)24.34
Total debt (mrq)234k
Total debt/equity (mrq)1.80%
Current ratio (mrq)5.94
Book value per share (mrq)10.68

Cash flow statement

Operating cash flow (ttm)-17.35M
Levered free cash flow (ttm)-10.09M